feed,title,long_url,short_url
Benzinga,"This Reopening Stock Has A Better 1-Year Return Than Moderna, Pfizer, BioNTech, Novavax And Vaxart",https://benzinga.com/markets/cryptocurrency/22/02/25686354/this-reopening-stock-has-a-better-1-year-return-than-moderna-pfizer-biontech-novavax-and-v,https://bit.ly/3rYOucC
